AXONICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.55 USD | -0.18% |
|
+0.22% | +8.55% |
| 16/05 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
| 30/04 | Axonics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AXONICS, INC. | Medical Devices & Implants | -0.18% | +0.22% | +8.55% | +27.45% | +124.05% | 3.45B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- AXNX Stock
- Charts Axonics, Inc.
- Comparison Chart